title: [Plasmacytoid dendritic cells as therapeutic targets in novel therapeutics for autoimmune diseases].
authors.forename: Tomoki
authors.initials: T
authors.lastname: Ito
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D003713:Dendritic Cells / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D051550:I-kappa B Kinase / Q000037:antagonists & inhibitors; D007370:Interferon Type I / Q000096:biosynthesis; D016898:Interferon-alpha / Q000096:biosynthesis; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000628:therapy; D008798:Mevalonic Acid / Q000378:metabolism; D051379:Mice; D058990:Molecular Targeted Therapy; D016328:NF-kappa B / Q000037:antagonists & inhibitors; D009570:Nitriles / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D013450:Sulfones / Q000494:pharmacology / Q000627:therapeutic use*; D020741:rho GTP-Binding Proteins / Q000096:biosynthesis
chemical_list: C434003:3-(4-methylphenylsulfonyl)-2-propenenitrile; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007370:Interferon Type I; D016898:Interferon-alpha; D016328:NF-kappa B; D009570:Nitriles; D013450:Sulfones; D051550:I-kappa B Kinase; D020741:rho GTP-Binding Proteins; D008798:Mevalonic Acid